Jennifer K. Litton
Researcher involved in a study on Durvalumab and Tremelimumab before surgery in breast cancer patients.
Best podcasts with Jennifer K. Litton
Ranked by the Snipd community
Mar 27, 2024 • 3min
Durvalumab and Tremelimumab Before Surgery in Patients With HR+/HER2-negative Breast Cancer
Researchers Haven R. Garber, Sreyashi Basu, Sonali Jindal, Zhong He, and Jennifer K. Litton discuss the feasibility and outcomes of using dual checkpoint inhibition with durvalumab and tremelimumab in HR+/HER2-negative breast cancer patients before surgery. The study showed mixed responses among patients, revealing both benefits and challenges of this treatment approach.
